Link Pharma Chem Ltd

Link Pharma Chem Limited — Trading Window closed from 01 October 2026 until 48 hours after declaration of Unaudited Financial Results for the quarter and half year ending 30 September 2026.

Chairman & WTD re-appointment

• Re-appointment of Satish G. Thakur as Chairman and Whole-time Director.
• Term: three-year tenure from 24 June 2026.
• Approval by AGM held on 20 August 2026.
• Profile: B.Sc., L.Tech; 43 years' industry experience; involved in operations since incorporation.
• Relationship: Father of Rishikesh Thakur, MD.
• Effective date: 24 June 2026.

MD Re-appointment

• Re-appointed as MD for three years from 24 September 2026, approved at AGM 20 August 2026.
• Profile: B.E. Polymer; 15+ years in chemical business; former GM-Operations.
• Relationship: Son of Satish G. Thakur, Chairman & Whole-time Director.

AGM details

• AGM held on 20 August 2026 at 11:40 AM via VC/OAVM.
• Record date: 13 August 2026.

Key resolutions

• Resolution 1: Adopt audited financial statements for year ended 31 March 2026; passed.
• Resolution 2: Re-appoint Satish Thakur as director by rotation; passed.
• Resolution 3: Ratify remuneration of Cost Auditors for FY 2026-27; passed.
• Resolution 4: Appoint Secretarial Auditor; passed.
• Resolution 5: Re-appoint Satish Thakur as Chairman & Whole-time Director; passed.
• Resolution 6: Re-appoint Rishikesh Thakur as Managing Director; passed.

Voting results

• Resolution 1: 99.74% in favour, 0.26% against.
• Resolution 2: 99.74% in favour, 0.26% against.
• Resolution 3: 99.74% in favour, 0.26% against.
• Resolution 4: 99.74% in favour, 0.26% against.
• Resolution 5: 99.74% in favour, 0.26% against.
• Resolution 6: 99.74% in favour, 0.26% against.

Director changes

• Satish Thakur re-appointed as Chairman & Whole-time Director.
• Rishikesh Thakur re-appointed as Managing Director.

Auditor appointments/remuneration

• Secretarial Auditor appointed.
• Cost Auditor remuneration ratified for FY 2026-27.

AGM Details

• 41st AGM held on 20 August 2026 at 11:40 a.m. via VC/OAVM.
• Meeting duration 11:40 a.m. to 12:05 p.m.
• Quorum: 47 members attended via VC.

Key Resolutions

• Adoption of Audited financial statements for FY 2025-26 and reports.
• Re-appointment of Satish Thakur as director (retiring by rotation).
• Ratification of Cost Auditors’ remuneration for 2026-27.
• Appointment of Secretarial Auditor.
• Re-appointment of Satish G. Thakur as Chairman & WTD.
• Re-appointment of Rishikesh Thakur as Managing Director.

Voting Process

• Remote e-voting conducted 17–19 August 2026; on-site AGM voting also available.
• Scrutinizer to file report; results to be posted on company website.

Attendees & Auditors

• Directors present via VC included Chairman Satish Thakur, MD Rishikesh Thakur, and independent directors.
• In attendance: CFO, Company Secretary, Statutory Auditor, Secretarial Auditor.
• Statutory auditors CNK & Associates LLP attended; no change in statutory audit.

Financial results

• Unaudited financial results for the quarter ended 30 June 2026 approved by the Board, with Limited Review Report.
• Annexure includes disclosures on changes in Directors and Key Managerial Personnel.

Operational note

• Operations described as a single segment: Manufacture and Sale of Chemicals.

AGM & Annual Report Access

• AGM: 41st AGM on 20 August 2026 at 11:30 IST via VC/OAVM.
• Cut-off for e-voting: 13 August 2026; remote voting 17–19 August 2026.
• Letter dispatched to shareholders without registered emails; web-link to Annual Report sent.
• Annual Report 2025-26 available online at https://linkpharmachem.co.in.

KYC & Shareholder Communications

• KYC/update reminder for physical shareholders per SEBI circular 2024/37, cut-off 24 July 2026.
• SEBI circular requires PAN, contact details, nomination updates; electronic payments mandated if folios lack updates.

Meeting Details

• Date: 05 August 2026; time and venue not disclosed.

Key Agenda Items

• Consider and approve unaudited standalone financial results for the quarter ended June 30, 2026.

Other Notes

• Trading window closed from 01 July 2026; opens 48 hours after results declaration.
• Intimation to BSE about the meeting provided on 26 June 2026.